Amgen (AMGN) |
United States |
$138.968B |
16.01 |
CSL (CSLLY) |
Australia |
$86.243B |
0.00 |
Gilead Sciences (GILD) |
United States |
$84.448B |
10.46 |
Vertex Pharmaceuticals (VRTX) |
United States |
$57.578B |
58.77 |
Biogen (BIIB) |
United States |
$52.242B |
8.97 |
Illumina (ILMN) |
United States |
$46.993B |
51.56 |
Regeneron Pharmaceuticals (REGN) |
United States |
$40.620B |
17.79 |
Alexion Pharmaceuticals (ALXN) |
United States |
$25.548B |
12.62 |
Incyte (INCY) |
United States |
$20.463B |
47.50 |
Seattle Genetics (SGEN) |
United States |
$20.283B |
0.00 |
SINO PHARMACEUT (SBMFF) |
Hong Kong, SAR China |
$17.057B |
0.00 |
Genmab (GNMSF) |
Denmark |
$14.991B |
66.21 |
BioMarin Pharmaceutical (BMRN) |
United States |
$14.602B |
0.00 |
Alnylam Pharmaceuticals (ALNY) |
United States |
$13.600B |
0.00 |
Galapagos (GLPG) |
Belgium |
$11.277B |
29.06 |
Exact Sciences (EXAS) |
United States |
$10.777B |
0.00 |
Bio-Rad Laboratories (BIO.B) |
United States |
$10.393B |
49.88 |
QIAGEN (QGEN) |
Netherlands |
$9.449B |
30.81 |
BeiGene (BGNE) |
Cayman Islands |
$9.241B |
0.00 |
Bio-Techne Corp (TECH) |
United States |
$8.323B |
55.71 |
Sarepta Therapeutics (SRPT) |
United States |
$8.303B |
0.00 |
Amarin (AMRN) |
Ireland |
$8.137B |
0.00 |
Moderna (MRNA) |
United States |
$7.088B |
0.00 |
Guardant Health (GH) |
United States |
$7.039B |
0.00 |
ACADIA Pharmaceuticals (ACAD) |
United States |
$6.820B |
0.00 |
Medicines (MDCO) |
United States |
$6.702B |
0.00 |
Reata Pharmaceuticals (RETA) |
United States |
$6.193B |
0.00 |
Horizon Therapeutics Public (HZNP) |
Ireland |
$6.110B |
15.53 |
ARGENX SE-ADR (ARGX) |
Netherlands |
$5.754B |
0.00 |
Exelixis (EXEL) |
United States |
$5.369B |
15.10 |
Ascendis Pharma (ASND) |
Denmark |
$4.898B |
0.00 |
BioNTech SE (BNTX) |
Germany |
$4.835B |
0.00 |
Repligen (RGEN) |
United States |
$4.613B |
83.59 |
China Biologic Products (CBPO) |
China |
$4.606B |
25.94 |
Bluebird Bio (BLUE) |
United States |
$4.488B |
0.00 |
Spark Therapeutics (ONCE) |
United States |
$4.237B |
0.00 |
Mirati Therapeutics (MRTX) |
United States |
$4.164B |
0.00 |
MorphoSys AG (MOR) |
Germany |
$4.062B |
0.00 |
CRISPR Therapeutics AG (CRSP) |
Switzerland |
$3.980B |
0.00 |
Intercept Pharmaceuticals (ICPT) |
United States |
$3.851B |
0.00 |
Blueprint Medicines (BPMC) |
United States |
$3.695B |
0.00 |
Immunomedics (IMMU) |
United States |
$3.482B |
0.00 |
Adaptive Biotechnologies (ADPT) |
United States |
$3.378B |
0.00 |
Alkermes (ALKS) |
Ireland |
$3.344B |
0.00 |
Genmab (GMAB) |
Denmark |
$3.108B |
6.40 |
MyoKardia (MYOK) |
United States |
$3.101B |
0.00 |
Halozyme Therapeutics (HALO) |
United States |
$2.853B |
0.00 |
UniQure (QURE) |
Netherlands |
$2.852B |
0.00 |
Emergent Biosolutions (EBS) |
United States |
$2.794B |
27.75 |
Amicus Therapeutics (FOLD) |
United States |
$2.739B |
0.00 |
NeoGenomics (NEO) |
United States |
$2.709B |
144.17 |
Acceleron Pharma (XLRN) |
United States |
$2.594B |
0.00 |
Ultragenyx Pharmaceutical (RARE) |
United States |
$2.463B |
0.00 |
Zai Lab (ZLAB) |
China |
$2.374B |
0.00 |
Arena Pharmaceuticals (ARNA) |
United States |
$2.354B |
5.47 |
RA PHARMCTL INC (RARX) |
United States |
$2.209B |
0.00 |
Insmed (INSM) |
United States |
$2.087B |
0.00 |
Myriad Genetics (MYGN) |
United States |
$1.921B |
28.39 |
Ligand Pharmaceuticals (LGND) |
United States |
$1.889B |
36.35 |
Dicerna Pharmaceuticals (DRNA) |
United States |
$1.841B |
0.00 |
Denali Therapeutics (DNLI) |
United States |
$1.743B |
0.00 |
Zymeworks (ZYME) |
Canada |
$1.737B |
0.00 |
Akcea Therapeutics (AKCA) |
United States |
$1.731B |
0.00 |
REGENXBIO (RGNX) |
United States |
$1.652B |
0.00 |
Momenta Pharmaceuticals (MNTA) |
United States |
$1.641B |
0.00 |
Editas Medicine (EDIT) |
United States |
$1.579B |
0.00 |
Nabriva Therapeutics AG (NBRV) |
Ireland |
$1.520B |
0.00 |
Epizyme (EPZM) |
United States |
$1.440B |
0.00 |
Sangamo Therapeutics (SGMO) |
United States |
$1.356B |
0.00 |
Alector (ALEC) |
United States |
$1.352B |
0.00 |
Innoviva (INVA) |
United States |
$1.324B |
3.90 |
Arvinas (ARVN) |
United States |
$1.314B |
0.00 |
Coherus BioSciences (CHRS) |
United States |
$1.283B |
0.00 |
Athenex (ATNX) |
United States |
$1.248B |
0.00 |
WAVE Life Sciences (WVE) |
Singapore |
$1.212B |
0.00 |
Principia Biopharma (PRNB) |
United States |
$1.184B |
0.00 |
Orchard Therapeutics (ORTX) |
United Kingdom |
$1.130B |
0.00 |
Zealand Pharma (ZLDPF) |
Denmark |
$1.129B |
0.00 |
Fate Therapeutics (FATE) |
United States |
$1.073B |
0.00 |
Zealand Pharma (ZEAL) |
Denmark |
$1.041B |
0.00 |
ZIOPHARM Oncology Inc (ZIOP) |
United States |
$0.958B |
0.00 |
Vanda Pharmaceuticals (VNDA) |
United States |
$0.915B |
7.69 |
Codexis (CDXS) |
United States |
$0.897B |
0.00 |
Achillion Pharmaceuticals (ACHN) |
United States |
$0.864B |
0.00 |
Intellia Therapeutics (NTLA) |
United States |
$0.864B |
0.00 |
Precision BioSciences (DTIL) |
United States |
$0.845B |
0.00 |
Pharming Group (PHGUF) |
Netherlands |
$0.840B |
0.00 |
Vericel (VCEL) |
United States |
$0.839B |
312.75 |
Anika Therapeutics (ANIK) |
United States |
$0.814B |
26.42 |
MiMedx (MDXG) |
United States |
$0.813B |
0.00 |
BAVARIAN NORDIC (BVNRY) |
Denmark |
$0.792B |
0.00 |
Twist Bioscience (TWST) |
United States |
$0.772B |
0.00 |
Heska (HSKA) |
United States |
$0.752B |
192.20 |
Revance Therapeutics (RVNC) |
United States |
$0.749B |
0.00 |
Adverum Biotechnologies (ADVM) |
United States |
$0.732B |
0.00 |
ANI Pharmaceuticals (ANIP) |
United States |
$0.726B |
12.39 |
DBV Technologies S.A (DBVT) |
France |
$0.726B |
0.00 |
Cara Therapeutics (CARA) |
United States |
$0.682B |
0.00 |
Clovis Oncology (CLVS) |
United States |
$0.664B |
0.00 |
UROGEN PHARMA (URGN) |
United States |
$0.652B |
0.00 |
Autolus Therapeutics (AUTL) |
United Kingdom |
$0.639B |
0.00 |
Mesoblast (MESO) |
Australia |
$0.625B |
0.00 |
Cellectis S.A (CLLS) |
France |
$0.619B |
0.00 |
BioDelivery Sciences (BDSI) |
United States |
$0.600B |
0.00 |
Sorrento Therapeutics (SRNE) |
United States |
$0.599B |
0.00 |
GENFIT S.A (GNFT) |
France |
$0.594B |
0.00 |
Basilea Pharmaceutica AG (BPMUF) |
Switzerland |
$0.590B |
0.00 |
Cytokineticsorporated (CYTK) |
United States |
$0.579B |
0.00 |
Retrophin (RTRX) |
United States |
$0.570B |
0.00 |
Intra-Cellular Therapies (ITCI) |
United States |
$0.552B |
0.00 |
PHARMA MAR SA (PHMMF) |
Spain |
$0.549B |
0.00 |
Kadmon Holdings (KDMN) |
United States |
$0.543B |
0.00 |
Agenus (AGEN) |
United States |
$0.541B |
0.00 |
AC Immune SA (ACIU) |
Switzerland |
$0.523B |
12.09 |
OXFORD BIOMEDCL (OXBDF) |
United Kingdom |
$0.514B |
0.00 |
Prothena (PRTA) |
Ireland |
$0.492B |
0.00 |
Stemline Therapeutics (STML) |
United States |
$0.487B |
0.00 |
Dynavax Technologies (DVAX) |
United States |
$0.478B |
0.00 |
Sinovac Biotech (SVA) |
China |
$0.460B |
0.00 |
Lexicon Pharmaceuticals (LXRX) |
United States |
$0.401B |
2.77 |
Merus (MRUS) |
Netherlands |
$0.397B |
0.00 |
AnaptysBio (ANAB) |
United States |
$0.392B |
0.00 |
Bellus Health (BLU) |
Canada |
$0.386B |
0.00 |
Xenon Pharmaceuticals (XENE) |
Canada |
$0.369B |
0.00 |
AMAG Pharmaceuticals (AMAG) |
United States |
$0.363B |
0.00 |
Arcus Biosciences (RCUS) |
United States |
$0.363B |
0.00 |
Puma Biotechnology (PBYI) |
United States |
$0.349B |
0.00 |
Cellular Biomedicine (CBMG) |
United States |
$0.348B |
0.00 |
Pfenex (PFNX) |
United States |
$0.344B |
0.00 |
Starpharma Holdings (SPHRY) |
Australia |
$0.343B |
0.00 |
OSMOTICA PHARM (OSMT) |
United States |
$0.338B |
0.00 |
PDL BioPharma (PDLI) |
United States |
$0.335B |
8.37 |
Avid Bioservices (CDMO) |
United States |
$0.324B |
0.00 |
Gritstone Oncology (GRTS) |
United States |
$0.301B |
0.00 |
Kindred Biosciences (KIN) |
United States |
$0.300B |
0.00 |
Geron (GERN) |
United States |
$0.298B |
0.00 |
CytomX Therapeutics (CTMX) |
United States |
$0.296B |
0.00 |
Kamada (KMDA) |
Israel |
$0.293B |
8.56 |
Cue Biopharma (CUE) |
United States |
$0.290B |
0.00 |
Compugen (CGEN) |
Israel |
$0.281B |
0.00 |
Albireo Pharma (ALBO) |
United States |
$0.271B |
0.00 |
Cel-Sci (CVM) |
United States |
$0.267B |
0.00 |
Seres Therapeutics (MCRB) |
United States |
$0.260B |
0.00 |
MannKind (MNKD) |
United States |
$0.256B |
0.00 |
Sutro Biopharma (STRO) |
United States |
$0.254B |
0.00 |
ADMA Biologics Inc (ADMA) |
United States |
$0.251B |
0.00 |
Scholar Rock Holding (SRRK) |
United States |
$0.248B |
0.00 |
Inovio Pharmaceuticals (INO) |
United States |
$0.247B |
0.00 |
Aeglea BioTherapeutics (AGLE) |
United States |
$0.234B |
0.00 |
Exicure (XCUR) |
United States |
$0.230B |
0.00 |
Biofrontera AG (BFRA) |
Germany |
$0.226B |
0.00 |
Theratechnologies (THTX) |
Canada |
$0.223B |
0.00 |
Protagonist Therapeutics (PTGX) |
United States |
$0.221B |
0.00 |
Senesco Technologies (ELOX) |
United States |
$0.219B |
0.00 |
Spero Therapeutics (SPRO) |
United States |
$0.217B |
0.00 |
ChromaDex (CDXC) |
United States |
$0.217B |
0.00 |
Pieris Pharmaceuticals (PIRS) |
United States |
$0.216B |
0.00 |
POXEL SA FRANCE (PXXLF) |
France |
$0.213B |
0.00 |
XOMA (XOMA) |
United States |
$0.210B |
0.00 |
Athersys (ATHX) |
United States |
$0.205B |
0.00 |
Syros Pharmaceuticals (SYRS) |
United States |
$0.201B |
0.00 |
Mersana Therapeutics (MRSN) |
United States |
$0.200B |
0.00 |
Syndax Pharmaceuticals (SNDX) |
United States |
$0.197B |
0.00 |
Aquinox Pharmaceuticals (NLTX) |
United States |
$0.187B |
0.00 |
Palatin Technologies (PTN) |
United States |
$0.186B |
5.09 |
Affimed (AFMD) |
Germany |
$0.178B |
0.00 |
ARAVIVE, INC (ARAV) |
United States |
$0.176B |
0.00 |
IVERIC Bio (ISEE) |
United States |
$0.170B |
0.00 |
EYEPOINT PHARMACEUTICALS, INC (EYPT) |
United States |
$0.167B |
0.00 |
Dyadic (DYAI) |
United States |
$0.163B |
0.00 |
Cerecor (CERC) |
United States |
$0.163B |
0.00 |
CorMedix Inc (CRMD) |
United States |
$0.155B |
0.00 |
Alcobra (ARCT) |
United States |
$0.153B |
0.00 |
Abeona Therapeutics (ABEO) |
United States |
$0.153B |
0.00 |
NantKwest (NK) |
United States |
$0.151B |
0.00 |
VBI Vaccines (VBIV) |
United States |
$0.147B |
0.00 |
Fortress Biotech (FBIO) |
United States |
$0.146B |
0.00 |
Five Prime Therapeutics (FPRX) |
United States |
$0.146B |
0.00 |
TELA Bio (TELA) |
United States |
$0.145B |
0.00 |
Prometic Life Sciences (LMNL) |
Canada |
$0.140B |
0.00 |
Bicycle Therapeutics (BCYC) |
United Kingdom |
$0.136B |
0.00 |
Newron Pharmaceuticals SpA (NWPHF) |
Italy |
$0.134B |
0.00 |
Aptinyx (APTX) |
United States |
$0.134B |
0.00 |
Northwest Biotherapeutics (NWBO) |
United States |
$0.134B |
0.00 |
Enzo Biochem (ENZ) |
United States |
$0.131B |
0.00 |
Novavax (NVAX) |
United States |
$0.130B |
0.00 |
Windtree Therapeutics (WINT) |
United States |
$0.129B |
0.00 |
Nymox Pharmaceutical (NYMX) |
Canada |
$0.129B |
0.00 |
Arbutus Biopharma (ABUS) |
Canada |
$0.128B |
0.00 |
Adaptimmune Therapeutics (ADAP) |
United Kingdom |
$0.128B |
0.00 |
Arsanis (XFOR) |
United States |
$0.127B |
0.00 |
Nicox SA (NICXF) |
France |
$0.126B |
0.00 |
Celyad SA (CYAD) |
Belgium |
$0.126B |
0.00 |
SESEN BIO, INC (SESN) |
United States |
$0.126B |
0.00 |
BioTime (LCTX) |
United States |
$0.123B |
6.31 |
AVEO Pharmaceuticals (AVEO) |
United States |
$0.121B |
0.00 |
OvaScience (MLND) |
United States |
$0.105B |
0.00 |
Emmaus Life Sciences (EMMA) |
United States |
$0.103B |
0.00 |
Verastem (VSTM) |
United States |
$0.102B |
0.00 |
Paratek Pharmaceuticals (PRTK) |
United States |
$0.101B |
0.00 |
Strongbridge Biopharma (SBBP) |
United States |
$0.098B |
2.62 |
Aduro Biotech (ADRO) |
United States |
$0.096B |
0.00 |
Menlo Therapeutics (MNLO) |
United States |
$0.095B |
0.00 |
PHASEBIO PHARMA (PHAS) |
United States |
$0.094B |
0.00 |
ASLAN Pharmaceuticals (ASLN) |
Singapore |
$0.088B |
0.00 |
Acorda Therapeutics (ACOR) |
United States |
$0.088B |
0.00 |
Antibe Therapeutics (ATBPF) |
Canada |
$0.086B |
0.00 |
Adocia (ADOCY) |
France |
$0.086B |
0.00 |
VTv Therapeutics (VTVT) |
United States |
$0.083B |
0.00 |
Liquidia Technologies (LQDA) |
United States |
$0.079B |
0.00 |
ANIXA BIOSCIENCES INC (ANIX) |
United States |
$0.076B |
0.00 |
Selecta Biosciences (SELB) |
United States |
$0.074B |
0.00 |
Vaccinex (VCNX) |
United States |
$0.074B |
0.00 |
Synlogic (SYBX) |
United States |
$0.072B |
0.00 |
Catabasis Pharmaceuticals (CATB) |
United States |
$0.071B |
0.00 |
Clearside Biomedical (CLSD) |
United States |
$0.068B |
0.00 |
Organovo Holdings (ONVO) |
United States |
$0.066B |
0.00 |
Prima BioMed (IMMP) |
Australia |
$0.063B |
0.00 |
Catalyst Biosciences (CBIO) |
United States |
$0.063B |
0.00 |
Trevena (TRVN) |
United States |
$0.062B |
0.00 |
Spring Bank Pharmaceuticals (SBPH) |
United States |
$0.062B |
0.00 |
Pluristem Therapeutics (PSTI) |
Israel |
$0.060B |
0.00 |
Curis (CRIS) |
United States |
$0.059B |
0.00 |
NewLink Genetics (NLNK) |
United States |
$0.059B |
0.00 |
Merrimack Pharmaceuticals (MACK) |
United States |
$0.059B |
0.00 |
Applied Genetic Technologies (AGTC) |
United States |
$0.055B |
0.00 |
Idera Pharmaceuticals (IDRA) |
United States |
$0.052B |
0.00 |
AIT Therapeutics (XAIR) |
United States |
$0.050B |
0.00 |
AquaBounty Technologies (AQB) |
United States |
$0.048B |
0.00 |
Checkpoint Therapeutics (CKPT) |
United States |
$0.048B |
0.00 |
Orgenesis (ORGS) |
United States |
$0.046B |
2.97 |
Protalix BioTherapeutics (PLX) |
Israel |
$0.046B |
0.00 |
Vascular Biogenics (VBLT) |
Israel |
$0.043B |
0.00 |
Sunesis Pharmaceuticals (SNSS) |
United States |
$0.043B |
0.00 |
Aridis Pharmaceuticals (ARDS) |
United States |
$0.043B |
0.00 |
AmpliPhi Biosciences (ARMP) |
United States |
$0.042B |
0.00 |
Celldex Therapeutics (CLDX) |
United States |
$0.040B |
0.00 |
Oncobiologics (OTLK) |
United States |
$0.038B |
0.00 |
Stellar Biotechnologies (EDSA) |
Canada |
$0.036B |
0.00 |
Alimera Sciences (ALIM) |
United States |
$0.036B |
0.00 |
Evogene (EVGN) |
Israel |
$0.035B |
0.00 |
DiaMedica Therapeutics (DMAC) |
United States |
$0.034B |
0.00 |
Celsion (CLSN) |
United States |
$0.033B |
0.00 |
BioCardia (BCDA) |
United States |
$0.031B |
0.00 |
VIVUS (VVUS) |
United States |
$0.030B |
0.00 |
Fibrocell Science Inc (FCSC) |
United States |
$0.029B |
16.61 |
Aptevo Therapeutics (APVO) |
United States |
$0.029B |
0.00 |
INNOVATE BIOPHARMACEUTICALS, INC (INNT) |
United States |
$0.027B |
0.00 |
Caladrius Biosciences (CLBS) |
United States |
$0.027B |
0.00 |
Novogen (KZIA) |
Australia |
$0.026B |
0.00 |
Apricus Biosciences (SEEL) |
United States |
$0.025B |
0.00 |
Entera Bio (ENTX) |
Israel |
$0.025B |
0.00 |
Aerpio Pharmaceuticals (ARPO) |
United States |
$0.024B |
0.00 |
Bionano Genomics (BNGO) |
United States |
$0.024B |
0.00 |
PLANET GREEN HOLDINGS CORP (PLAG) |
China |
$0.023B |
0.00 |
Signal Genetics (MGEN) |
United States |
$0.022B |
0.00 |
Unum Therapeutics (UMRX) |
United States |
$0.021B |
0.00 |
Soligenix (SNGX) |
United States |
$0.021B |
0.00 |
VistaGen Therapeutics (VTGN) |
United States |
$0.019B |
0.00 |
CollPlant Holdings (CLGN) |
Israel |
$0.019B |
0.00 |
AEterna Zentaris (AEZS) |
United States |
$0.018B |
0.00 |
Aytu Bioscience (AYTU) |
United States |
$0.017B |
0.00 |
Pulmatrix (PULM) |
United States |
$0.017B |
0.00 |
TOCAGEN INC (TOCA) |
United States |
$0.015B |
0.00 |
IMMURON (IMRN) |
Australia |
$0.014B |
0.00 |
MYOS RENS Technology (MYOS) |
United States |
$0.013B |
0.00 |
Prana Biotechnology (ATHE) |
Australia |
$0.013B |
0.00 |
TrovaGene (TROV) |
United States |
$0.010B |
0.00 |
Advaxis (ADXS) |
United States |
$0.010B |
0.00 |
Titan Pharmaceuticals (TTNP) |
United States |
$0.010B |
0.00 |
TRACON Pharmaceuticals (TCON) |
United States |
$0.010B |
0.00 |
Cyclacel Pharmaceuticals (CYCC) |
United States |
$0.009B |
0.00 |
IBio (IBIO) |
United States |
$0.009B |
0.00 |
Cesca Therapeutics (THMO) |
United States |
$0.009B |
0.00 |
Cleveland BioLabs (CBLI) |
United States |
$0.009B |
0.00 |
Genetic Technologies (GENE) |
Australia |
$0.008B |
0.00 |
Benitec Biopharma (BNTC) |
Australia |
$0.007B |
0.00 |
BioPharmX (BPMX) |
United States |
$0.005B |
0.00 |
Neuralstem (SNCA) |
United States |
$0.004B |
0.00 |